| DESCRIPTION OF ENHANCEMENTS |
ATTENTION: This patch includes a new Graphical User Interface (GUI)
Request Analysis (IMR SFG IRA) Phase III/Phase IV, as well as
modifications requested by the BCMA and Inpatient Medications
workgroups. The Inpatient Pharmacy patch PSJ*5*153 is also being
released as part of these enhancements.
1. In order to allow facilities to select a timeframe that better matches
their site policies, the site parameter that sets the amount of time
that nurses have to document the PRN Effectiveness assessment is being
expanded from 240 to 960 minutes.
executable file. Installation of this GUI is required immediately after
2. A new site parameter was added to the PARAMETERS file (#8989.5) &
PARAMETERS DEFINTION file (#8989.51) to allow sites to prohibit
administration of non-nurse verified medication orders, or to display a
warning before administering non-nurse verified medication orders.
Facilities will be able to set this option by division.
3. The Missed Medications report will now include a "Verified" column that
will contain the initials of the nurse who verified the order, or three
asterisks, indicating that the order was not nurse verified.
the KIDS install for the Patch to function.
4. A visual indicator will be displayed on the BCMA Virtual Due List (VDL)
which will reflect whether an order has provider override reasons
associated with the order.
5. If the override information exists for an order, it will also be
displayed on the order detail report.
For retrieval and installation instructions, please see the Client
Installation Instructions section.
The Allergy and Alerts Project addresses enhancements identified during
Inpatient Medications Requirementxs for Special Focus Group Initial
|
